Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer. - Wikidata - awgldk - TriplyDB

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

http://www.wikidata.org/entity/Q35623109

about

Uncovering the role of p53 splice variants in human malignancy: a clinical perspective The significance of p53 isoform expression in serous ovarian cancer Immunoexpression and prognostic role of p53 in different subtypes of epithelial ovarian carcinoma Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer Increased Δ133p53 mRNA in lung carcinoma corresponds with reduction of p21 expression p53 Isoforms: Key Regulators of the Cell Fate Decision.Expression of p53β and Δ133p53 isoforms in different gastric tissues.Role of p53 isoforms and aggregations in cancer.Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ.Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?p73 coordinates with Δ133p53 to promote DNA double-strand break repair.High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.p53 Isoforms and Their Implications in Cancer

P2860

Q27015641-B7EAC3E8-724C-4768-B8B8-3EDCE1DDBA67 Q36192372-94466E32-1BED-4649-8211-38F5F8B12716 Q36682128-919C5953-4198-48B8-BC96-1E277CD3BD95 Q37306546-5422B774-A07D-410C-920B-E57264B46615 Q37720213-4309F14C-21E5-412B-83F3-BCB38DF48F63 Q38708506-3A8ECB3A-4712-443B-A00F-DB69BD496304 Q38815869-8D3B88D4-DE22-4197-8430-39ACE482C307 Q38883419-0D34F41A-515E-4C0F-BC3D-EDBC2FFAAA46 Q42160338-6DE9FCB1-341C-4398-A029-27D3A30F6317 Q42787889-31C21C35-2841-4C6B-B163-26FDB0C26168 Q47757816-F91F4B1B-6338-4F5F-9CA6-1C904142BA94 Q52671036-DEC3F4AE-B944-47F9-831D-968DEF6F95A6 Q55452619-74B57365-CEE5-4BB2-8FF5-8FC1B752DC66 Q58702684-71F07F15-59DD-4470-8427-6558E6E60A8B

P2860

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

http://www.wikidata.org/entity/Q35623109

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

@ast

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

@en

type

label

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

@ast

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

@en

prefLabel

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

@ast

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

@en

P1433

Q35623109-CBF5EFB6-542C-4788-8924-501EAE876DB2

P1476

Q35623109-BAE26674-B12F-496D-B5A2-1A30F42198E3

P2093

Q35623109-304FDAD5-F92C-44BF-9441-0E6A13224148

Q35623109-37D02F81-C3E2-48F2-8748-BDF2911FEE0E

Q35623109-3E8B03E5-99EF-4391-9059-72D108EFF660

Q35623109-415EB724-9C41-4F51-9597-95E86E113B41

Q35623109-5DC5E9CB-A6F7-40AB-8ACB-A3E69386BF7A

Q35623109-6A5CCD6F-3225-4121-AB8B-3A52669F869D

Q35623109-73D354F8-C36B-4F9D-ABD1-42CFD1003E0D

Q35623109-97ADA9F3-5A6A-43EB-A98C-350D016F65C1

Q35623109-A48DD33C-F555-4BE2-B071-7591A274F45D

Q35623109-B7E4A589-3916-4F79-AE04-0CB2993C965C

P2860

Q35623109-0C740E9F-9006-45C0-9CA3-B07BB1B9E41A

Q35623109-1646A520-A5D7-4C33-82AD-69BAE3FBF388

Q35623109-18D91737-CEEB-4FC3-BF77-1AE61A67C516

Q35623109-1E08F4A7-5B1E-4BCA-AC4B-3672B2F8C722

Q35623109-1E2BD973-47ED-430D-840B-4D2FE52BC625

Q35623109-2E8E1E9B-D3FA-4752-B9AB-CFA10B39E295

Q35623109-35DC1701-7D3E-4F7D-8BAA-0492F6E3E23C

Q35623109-3BF43BB6-99B1-406C-B28C-EB98D5EBF6CE

Q35623109-4ADBFD7B-66ED-4F5C-AEE3-F251A7C5E134

Q35623109-4CC2A94D-7C24-422B-BABE-5DE9B03E35AB

P2888

Q35623109-BE4F4932-614E-488B-A9D7-BDB8F12FEB6D

P304

Q35623109-433634B4-658A-44CD-9946-DE8BCCC9ACEA

P31

Q35623109-3DC64DB9-D4D9-4B89-B47A-92E10FF9212B

P356

Q35623109-EBB90DC4-2F2F-4A7C-B8E3-2B7D863940BE

P407

Q35623109-C6DB5214-2244-4186-8018-FBBF06BDF987

P433

Q35623109-51DC26F8-89E6-441F-AF0A-6A967988ACA0

P478

Q35623109-80D2F411-5010-4D6E-B29C-94A6CF291B23

P50

Q35623109-EB48E779-357F-448B-9E4C-F33E91F9D1B4

P577

Q35623109-4902B56A-BAF3-4531-99EE-718041AA9C3D

P5875

Q35623109-AE5026A7-6E50-4F9C-A646-CD4F5B0ECCCC

P698

Q35623109-45B9C385-0DB4-4522-A8ED-1AC23D5FE08A

P921

Q35623109-A43F7E33-9D89-4FA1-A59F-24EFA73DEF23

P932

Q35623109-85A9B0C7-7064-464B-AF7F-EAFB90F7FA1E

P356

P1433

British Journal of Cancer

P1476

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

@en

P2093

A Berger

http://www.w3.org/2001/XMLSchema#string

A G Zeimet

http://www.w3.org/2001/XMLSchema#string

A Wolf

http://www.w3.org/2001/XMLSchema#string

C Marth

http://www.w3.org/2001/XMLSchema#string

E I Braicu

http://www.w3.org/2001/XMLSchema#string

E Schuster

http://www.w3.org/2001/XMLSchema#string

G Hager

http://www.w3.org/2001/XMLSchema#string

G Hofstetter

http://www.w3.org/2001/XMLSchema#string

H Ulmer

http://www.w3.org/2001/XMLSchema#string

I Cadron

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

Regulation of human p53 activity and cell localization by alternative splicing

p53 isoforms can regulate p53 transcriptional activity.

Mutant p53 gain-of-function in cancer.

Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.

Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafish.

Cancer of the ovary.

Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.

Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.

P2888

P304

1593-1599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.433

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Robert Zeillinger

P577

2011-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51726851

http://www.w3.org/2001/XMLSchema#string

P698

22009029

http://www.w3.org/2001/XMLSchema#string

P921

P932

3242533

http://www.w3.org/2001/XMLSchema#string